Special Issue: Health promoting activities of phytochemicals. (Special Issue: Health promoting activities of phytochemicals.)

This issue contains 17 papers providing information on the newly discovered biological activities of phytochemicals and plant extracts that can be potentially developed as treatments for various disorders (COVID-19, cancer, skin disorders, allergies and inflammation, among others) and the underlying mechanisms by which they affect biological systems.

Syzygium aromaticum as a possible source of SARS-CoV-2 main protease inhibitors: evidence from a computational investigation

SARS-CoV-2, a new and fast circulating coronavirus strain, infected over 214 countries and territories worldwide and caused global health emergencies. The absence of appropriate medicines and vaccinations has further complicated the condition. SARS-CoV-2 main protease (Mpro) is crucial for its propagation, and it is considered a striking target. This study used several computational approaches to determine the probable antagonist of SARS-CoV-2 Mpro from bioactive phytochemicals of Syzygium aromaticum. A total of 20 compounds were screened through in silico approach. The molecular dynamics simulation studies were then carried out for further insights. We found crategolic acid, oleanolic acid, and kaempferol have considerable binding affinity and important molecular contacts with catalytic pocket residues, His41-Cys145. The pharmacological properties through ADMET analysis also showed that these compounds could be used as safe drug candidates. The molecular dynamics simulation study further confirmed these compound's stability with Mpro. However, further detailed in-vitro and in-vivo analyses are compulsory to evaluate the real potentiality of identified compounds.

Survey on the level of knowledge of medicinal plants used against Coronavirus disease, influenza and colds among travelers who came for the COVID-19 test at the Institut Pasteur de C..te d'Ivoire

Objective: This study was conducted to identify medicinal plants in the fight against Coronavirus disease, influenza and colds cited by travelers who came for their Covid test at the Institut Pasteur of C..te d'Ivoire. Methodology and Results: A semi-structured interview was conducted with 527 travelers from April 1 to June 30, 2021. The interviewed travelers were predominantly male (69.4%). Travelers going to France (28.46%) were the most numerous. The most represented age groups were 41-64 (43.83%) and 25-40 (43.26%). When the level of education is considered, the surveyed travelers have a higher level of education (89.94%). Entrepreneurs (13.85%), traders (12.66%), company directors (12.33%), students (8.54%) and health workers (6.45%) are the majority. Only 21.63% of travelers used traditional medicine in the last 12 months prior to the survey. Various plants are used to fight (33.43%) or prevent (56.57%) Coronavirus disease (7.02%), influenza (3.60%) and colds (2.84%). In total, 13 species of medicinal plants divided into 13 genera and 13 families were cited. Azadirachta indica (Meliaceae) with citation frequencies (cf) of 22%, Zingiber officinale (Zingiberaceae) with cf of 21% and Citrus limon (Rutaceae) with cf of 14% were the most cited species. Conclusion and application of results: These plants could be used for research and development of phytomedicines against Coronavirus, influenza and cold.